Subscribe
Liver cancer
What changes occur in the hair during the early stages of liver cancer?
Liver cancer is a common type of tumor in the digestive system in China, and patients with early-stage liver cancer generally do not experience significant changes in their hair. This is because the tumors in early-stage liver cancer patients are relatively small, and the treatment often involves surgical removal, which does not require chemotherapy or other anti-tumor treatments, so the impact on the patient's hair is minimal. As the disease progresses, some patients may need to undergo chemotherapy or other anti-tumor treatments, which can lead to hair loss or changes in hair color. However, hair changes after chemotherapy in liver cancer patients are generally reversible, and hair can regrow after the end of chemotherapy. Changes in hair color, on the other hand, are generally caused by pigment deposition induced by some chemotherapy drugs.
Late-stage liver cancer vomiting is what symptom?
Patients with advanced liver cancer have no signs before vomiting. If patients with advanced liver cancer experience vomiting, it is often accompanied by other symptoms. For example, some patients may experience diarrhea and body wasting due to loss of appetite, and the nature of the vomiting can vary. Some may vomit food, while others may vomit blood. If the vomit contains blood, it is urgent to consult a doctor promptly for targeted prevention and treatment.
How to effectively treat advanced liver cancer?
In the late stages of liver cancer, due to the spread of lesions, it is very easy to cause the failure of multiple organs such as the liver, heart, and kidneys, ultimately endangering the patient's life. Therefore, effective treatment methods must be adopted to delay the progression of the disease as much as possible. Currently, effective treatment methods include radiotherapy, chemotherapy, targeted therapy, immunotherapy, traditional Chinese medicine, and some physical therapies. Commonly used clinical treatments include radiofrequency ablation and microwave ablation. Radiotherapy is also a local treatment method, while targeted therapy and chemotherapy immunotherapy are systemic comprehensive treatments. Currently, the effects of targeted therapy for liver cancer are satisfactory, but the effects of chemotherapy and immunotherapy are poor. Most patients need these treatments combined to exert their effective anti-tumor treatment functions.
Is bleeding when brushing teeth an early sign of liver cancer?
When a patient has liver cancer, one symptom can be gingival bleeding. Because when a patient has liver cancer, some coagulation factors in the blood are affected, and the patient may frequently experience repeated dental bleeding. Therefore, it is suggested that patients should undergo early diagnostic tests and adopt specific treatment plans. However, repeated gingival bleeding in a patient does not necessarily indicate early-stage liver cancer, as some hematological diseases can also lead to repeated gingival bleeding, such as common thrombocytopenia and some patients with gingivitis. If long-term oral hygiene is neglected, the gingival tissue stays in a state of chronic inflammation, and acute inflammation can lead to bleeding while brushing teeth.
How does an ultrasound show early-stage liver cancer?
Liver cancer can be detected in its early stages through Doppler ultrasound examination, which may reveal single or multiple abnormal masses within the liver. These masses often vary in size and have irregular edges, with blood flow signals inside. If liver cancer is suspected from the Doppler ultrasound, further examination with an abdominal CT or MRI can provide more detailed information about the lesions to aid in judgment. A definitive diagnosis relies on surgical removal or percutaneous liver biopsy to obtain local tissue for pathological confirmation. Patients with early-stage diagnosed liver cancer should undergo surgical treatment as soon as possible, and those who can have radical resection generally have a better prognosis.
Can liver cancer cause back pain?
Liver cancer can potentially cause back pain for several reasons: First, the tumor from liver cancer may directly metastasize to locations such as the lumbar vertebrae, resulting in significant and persistent back pain. Second, liver cancer can metastasize to the kidneys via the bloodstream, which clinically can also manifest as back pain and symptoms of blood in the urine. Third, liver cancer can cause kidney function impairment, which likewise can lead to symptoms of back pain. Fourth, patients with liver cancer may experience back pain due to urinary tract infections, which can appear particularly when the infection is severe and the patient's immune system is compromised.
Do early-stage liver cancer patients experience fatigue?
Patients with early-stage liver cancer generally do not exhibit symptoms of fatigue, which are more commonly seen in patients with mid to late-stage liver cancer. The clinical symptoms of early-stage liver cancer are generally not typical, with a minority of patients experiencing reduced appetite and discomfort or mild pain in the liver area. Furthermore, early-stage liver cancer is often discovered during physical examinations or incidentally. Fatigue in liver cancer patients is mostly due to hypoalbuminemia, moderate to severe anemia, or toxic side effects caused by certain anticancer treatments. Hypoalbuminemia occurs because the growth of liver cancer consumes a large amount of protein, and liver dysfunction leads to insufficient synthesis of both protein and glycogen, resulting in malnutrition in patients. After experiencing weight loss, patients often show signs of fatigue. The pathological changes in liver cancer can lead to moderate to severe anemia, which, in turn, significantly contributes to fatigue. Additionally, some medications used in treating liver cancer can cause fatigue due to their toxic side effects.
How to protect the liver in the late stages of liver cancer
If liver cancer has reached an advanced stage, this indicates that the patient's condition is very serious, and there is no possibility of cure. It is recommended that the patient take some Chinese herbal medicines for liver protection and maintenance. However, the patient must regulate their condition and control the development of the disease through medication under the guidance of a doctor, in order to prolong their life. However, the specific treatment plan should be determined based on the specific condition of each patient, following the guidance of the doctor for treatment.
Should the gallbladder be removed in the early stage of liver cancer?
Whether early-stage liver cancer patients need to have their gallbladder removed depends on the location of the tumor. For liver cancers located close to the gallbladder, gallbladder removal is generally necessary. For liver cancer lesions that are farther from the gallbladder, it is usually sufficient to only remove the liver tumor, or to perform a resection of the local liver segment or sub-segment. Additionally, for early-stage liver cancer patients to undergo surgery, certain conditions must be met: the tumor must be five centimeters or smaller, there should be no cancerous thrombus in the main trunk of the portal vein, the liver cancer tumor should not involve the semi-dry or full-dry circumstances, and the liver function should be compensatory. Under these conditions, an effort should be made to perform liver tumor resection. Generally, cancers located in the left lobe of the liver require local resection, either of a liver segment or sub-segment, and sometimes resection of the liver lobe may be performed. Tumors located in the right lobe of the liver or the hepatic portal area require local tumor resection.
Can alpha-fetoprotein diagnose liver cancer?
Alpha-fetoprotein, also known as AFP, reflects the function of the liver and whether there are any diseases present. The accuracy and specificity of alpha-fetoprotein in diagnosing liver cancer are relatively high. In non-pregnant individuals, whether male or female, an elevated alpha-fetoprotein level should raise suspicions of liver disease, and it is advisable to promptly undergo ultrasound or CT scans to determine the presence of liver cancer or other liver diseases. However, during pregnancy, as the fetus grows and develops, a certain amount of alpha-fetoprotein is released. Therefore, when testing the blood of pregnant women, an increase in alpha-fetoprotein is observed. This condition is a physiological change and does not indicate the occurrence of liver diseases such as liver cancer in women. Thus, alpha-fetoprotein can serve as an auxiliary method for diagnosing liver cancer, but only in non-pregnant individuals.